Moreover, researchers have reported that lower levels of high molecular weight adiponectin in postmenopausal women were significantly associated with a higher BMI, type 2 diabetes, hypertension, glucose, and insulin levels, and lower HDL-C levels (P < 0.01 for all) [42]. Here, ADIPOQ is linked to type 2 diabetes mellitus.